Best evidence in critical care medicine: Early antibiotics and survival from septic shock: It's about time

Canadian Journal of Anesthesia

Volumn 53, Issue 11, 2006, Pages 1157-1160

  Brindley, Peter G ^a   Zhu, Nancy ^a   Sligl, Wendy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DROTRECOGIN; STEROID; ANTIINFECTIVE AGENT;

ADULT; ANTIMICROBIAL THERAPY; APACHE; CENTRAL VENOUS PRESSURE; CLINICAL FEATURE; DRUG EFFICACY; DRUG RESISTANCE; EARLY INTERVENTION; EVIDENCE BASED MEDICINE; FLUID RESUSCITATION; HEALTH CARE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HUMAN; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; MULTIVARIATE ANALYSIS; PRESSOR RESPONSE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SHORT SURVEY; SURVIVAL RATE; TREATMENT OUTCOME; WATER TREATMENT; FLUID THERAPY;

ANTI-BACTERIAL AGENTS; CRITICAL CARE; FLUID THERAPY; HUMANS; SEPSIS; SHOCK, SEPTIC;

EID: 33751039449     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022884     Document Type: Short Survey

References (9)

1. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32: 858-72.
2. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164: 637-44.
3. MacArthur RD, Miller M, Albertson T, et al. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis 2004, 38: 284-8.
4. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.
6. Anonymous. Part 1: introduction to the International Guidelines 2000 for CPR and ECC: a consensus on science. Circulation 2000; 102(8 Suppl): 1-11.
7. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
8. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and Safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709.
9. Sorensen TI, Nielsen GG, Andersen PK, Teasdak TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-32.